Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018

Blood Cancer J. 2021 Nov 13;11(11):179. doi: 10.1038/s41408-021-00574-5.

Manette A W Dinnessen^{1

2}, Otto Visser³, Sanne H Tonino⁴, Eduardus F M Posthuma^{5

6}, Nicole M A Blijlevens⁷, Marie José Kersten⁴, Pieternella J Lugtenburg⁸, Avinash G Dinmohamed^{9

3

10

11}

¹ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. [email protected].
² Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. [email protected].
³ Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁴ Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
⁵ Department of Internal Medical, Reinier de Graaf Gasthuis, Delft, The Netherlands.
⁶ Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
⁷ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁸ Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
⁹ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
¹⁰ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
¹¹ Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

No abstract available

Publication types